Evidence map›Paper›PMID 26505969›Full record

ArticleAIDS patient care and STDs2015

Medication-Taking Practices of Patients on Antiretroviral HIV Therapy: Control, Power, and Intentionality.

Kathryn E Muessig, Abigail T Panter, Mary S Mouw, Kemi Amola, Kathryn E Stein, Joseph S Murphy, Eric M Maiese, David A Wohl

Open access · greenAbstract read
In one paragraph

Article in AIDS patient care and STDs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kathryn E Muessig1 Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Abigail T Panter2 Department of Psychology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Mary S Mouw3 Lineberger Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Kemi Amola4 School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Kathryn E Stein1 Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Joseph S Murphy4 School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Eric M Maiese5 Merck & Co, Inc. , Kenilworth, New Jersey.
David A Wohl4 School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
University of North Carolina at Chapel Hill · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
LINEBERGER CANCER CONTROL EDUCATION PROGRAMR25CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EARP, JO ANNE L, RIBISL, KURT M. · 1992 to 2016
$8.0M
Mentoring New Investigators in Criminal Justice HIV Prevention and TreatmentK24DA037101 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WOHL, DAVID A · 2014 to 2018
$911k
NCI NIH HHS R25 CA057726NIAID NIH HHS P30 AI50410NIDA NIH HHS K24 DA037101NIDA NIH HHS K24DA037101
6 · The paper itself

Abstract

Among people living with HIV (PLWH), adherence to antiretroviral therapy (ART) is crucial for health, but patients face numerous challenges achieving sustained lifetime adherence. We conducted six focus groups with 56 PLWH regarding ART adherence barriers and collected sociodemographics and ART histories. Participants were recruited through clinics and AIDS service organizations in North Carolina. Dedoose software was used to support thematic analysis. Participants were 59% male, 77% black, aged 23-67 years, and living with HIV 4-20 years. Discussions reflected the fluid, complex nature of ART adherence. Maintaining adherence required participants to indefinitely assert consistent control across multiple areas including: their HIV disease, their own bodies, health care providers, and social systems (e.g., criminal justice, hospitals, drug assistance programs). Participants described limited control over treatment options, ART's impact on their body, and inconsistent access to ART and subsequent inability to take ART as prescribed. When participants felt they had more decision-making power, intentionally choosing whether and how to take ART was not exclusively a decision about best treating HIV. Instead, through these decisions, participants tried to regain some amount of power and control in their lives. Supportive provider relationships assuaged these struggles, while perceived side-effects and multiple co-morbidities further complicated adherence. Adherence interventions need to better convey adherence as a continuous, changing process, not a fixed state. A perspective shift among care providers could also help address negative consequences of the perceived power struggles and pressures that may drive patients to exert control via intentional medication taking practices.

Indexed as

Antiretroviral Therapy, Highly ActiveIntentionMedication AdherenceAdultAnti-Retroviral AgentsFemaleFocus GroupsHealth PersonnelHIV InfectionsHumansMaleMiddle AgedNorth CarolinaPower, PsychologicalQualitative ResearchSexual BehaviorAnti-Retroviral Agents

Identifiers

PMID26505969
PMCPMC4638213
OpenAlexW1888028661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.